Employment in a cohort of breast cancer patients

Villaverde, R. Molina; Batlle, Jaime Feliú; Yllan, A. Villalba; Gordo, A.M. Jiménez; Sánchez, A; Valiente, Belén San José; Barón, Manuel González

doi:10.1093/occmed/kqn092

Cited by 38 publications

(39 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The adverse effect of cancer progress and poor physical functioning on RTW has been shown in several previous studies (7,23,27). Corresponding to previous research, we found reemployment significantly associated with younger age and a professional status as an employee (24,27,45). Our regression analyses findings emphasize the importance of volitional factors for RTW.…”

Section: Discussionsupporting

confidence: 88%

“…Consistent with the literature, the perceived employer accommodation indicated a fairly positive attitude towards employment, work-related support, and necessary job changes (14,27,49) and emerged as a significant predictor for RTW.…”

Section: Discussionsupporting

confidence: 77%

“…Overall, studies indicate a steady increase of return to work (RTW) from on average 40% at six months post diagnosis to 62% at 12 months, 73% at 18 months, and 89% at 24 months. Factors significantly associated with a greater likelihood of being employed or RTW include perceived employer accommodation, flexible working arrangements, counseling, training and rehabilitation services, younger age, higher education, male gender, a lower physical symptom burden, cancer remission, shorter length of sick leave, and continuity of care (7,14,17,(23)(24)(25)(26)(27)(28).…”

mentioning

confidence: 99%

See 2 more Smart Citations

Predictors of employment among cancer survivors after medical rehabilitation – a prospective study

Mehnert¹,

Koch²

2012

Scand J Work Environ Health

121

101

View full text Add to dashboard Cite

Objectives This study aimed to (i) investigate cancer survivor's employment status one year after the completion of a medical rehabilitation program and (ii) identify demographic, cancer, and psychosocial, treatment-, and work-related predictors of return to work (RTW) and time until RTW.Methods A total of 1520 eligible patients were consecutively recruited on average 11 months post diagnosis and assessed at the beginning (t 0 ) (N=1148) and end of rehabilitation (t 1 ) (N=1060) and 12 months after rehabilitation (t 2 ) (N=750). Participants completed validated measures assessing functional impairments, pain, anxiety, depression, quality of life, social support, and work-related characteristics including work ability, sick leave absence, job requirements, work satisfaction, self-perceived employer accommodation, and perceived job loss. Physicians estimated the degree of cancer-entity-specific functional impairment. ResultsIn a mean time of six weeks after rehabilitation, 568 patients (76%) had returned to work. The multivariate hierarchical logistic regression analysis indicated that baseline RTW intention [odds ratio (OR) 6.22, 95% confidence interval (95% CI) 1.98-19.51], perceived employer accommodation (OR 1.93, 95% CI 0.33-0.99), high job requirements (OR=1.84, 95% CI 1.02-3.30), cancer recurrence or progression (OR=0.27, 95% CI 0.12 -0.63), baseline sick leave absence (OR=0.26, 95% CI 0.09-0.77), and problematic social interactions (OR=0.58, 95% CI 0.33-0.99) emerged as significant predictors for RTW. The explained variance of the total model was Nagelkerke's R²=0.59 (P<0.001). ConclusionOur findings emphasize the high relevance of motivational factors. Occupational motivation and skepticism towards returning to work should be carefully assessed at the planning of the rehabilitation program.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionsupporting

confidence: 77%

mentioning

confidence: 99%

See 1 more Smart Citation

Predictors of employment among cancer survivors after medical rehabilitation – a prospective study

Mehnert¹,

Koch²

2012

Scand J Work Environ Health

121

101

View full text Add to dashboard Cite

show abstract

“…This is however quite unsettling and can easily be interpreted as a form of discrimination. This has previously been identified by [16], although conversely, [38], report job discrimination was not experienced by their participants.…”

Section: Discussionsupporting

confidence: 62%

The Lived Experience of Women Returning to Work after Breast Cancer

Banning

Griffths

2014

Occup Med Health Aff

View full text Add to dashboard Cite

Breast cancer is a global concern and a common cancer in women. Treatment can involve chemotherapy, surgical intervention with possible radiation therapy. Many breast cancer survivors return to work, even though the availability of health care and occupational health services may be limited. This phenomenological study examined the return to work experience of six breast cancer survivors. In-depth, unstructured interviews were undertaken and analysed using an adapted version of Colaizzi's (1978) approach. Four themes emerged. Women noted that the impact of their disease on their work continued for some time. Some women gained an inner strength to progress their career on return to work. The provision of occupational health services emerged as a positive influence. These findings have implications for occupational health professionals, particularly the importance of positively supporting women so that the breast cancer return to work experience is fully understood.

show abstract

“…Dass einige Patientinnen dabei jedoch nicht den Umfang vor der Diagnosestellung erreichen, verdeutlicht eine Längsschnittstudie an Brustkrebspatientinnen [52]. Im Vergleich zu Frauen und Männern ohne Krebserkrankung ergeben drei Studien bei Patientinnen keine [40,48] Eine Studie an Brustkrebspatientinnen berichtet, dass die Mehrheit der Patientinnen ihre Diagnose Kollegen und Arbeitgebern mitteilt [59], während in einer früheren Studie nur 41% der Brustkrebspatientinnen ihren Vorgesetzten informiert haben [29]. Keine der quantitativen Studien untersucht systematisch die Rücksichtnahme des Arbeitgebers auf erkrankungs-und behandlungsbedingte Bedürfnisse von Patientinnen und Patienten.…”

Section: Arbeitssituationunclassified

Geschlechtsspezifische Aspekte der Rückkehr zur Arbeit bei Patientinnen und Patienten mit einer Krebserkrankung

Ullrich

Böttcher

Bergelt

2012

Bundesgesundheitsbl.

View full text Add to dashboard Cite

Due to improved prognosis most cancer survivors are nowadays able to return to work. This review explored gender-related differences in work-related outcomes after cancer. A systematic search of studies on work-related issues in cancer survivors published between January 2001 and July 2011 was conducted. 44 original publications met the inclusion criteria (adult cancer survivors, focus on work-related outcomes, gender-specific report of results). The results of these studies indicate that impaired work ability is more common among female cancer survivors than among male cancer survivors as well as the reduction of working hours and income losses. Supportive work environments seem to be particularly helpful for the successful and long-lasting re-integration of female survivors. More systematic research and separate analyses for women and men are needed to fully comprehend gender differences in work-related outcomes. Broader knowledge can then be helpful in creating gender-specific return-to-work interventions.

show abstract

Employment in a cohort of breast cancer patients

Abstract: Breast cancer survivors in this study encountered some problems in returning to work, mainly linked to the sequelae of their disease and its treatment rather than to discrimination by employers or colleagues.

Cited by 38 publications

References 8 publications

Predictors of employment among cancer survivors after medical rehabilitation – a prospective study

Predictors of employment among cancer survivors after medical rehabilitation – a prospective study

The Lived Experience of Women Returning to Work after Breast Cancer

Geschlechtsspezifische Aspekte der Rückkehr zur Arbeit bei Patientinnen und Patienten mit einer Krebserkrankung

Contact Info

Product

Resources

About